King of Prussia, PA (February 06, 2020)
Nearly 20 years after its inception, the MedRisk Instrument for Measuring Patient Satisfaction (MR-12) continues to be employed in international physical medicine research.
In addition to clinical outcomes, patient satisfaction can be a critical component of assessing treatment effectiveness.
Such was the case for a recent randomized control trial intended to measure electroacupuncture efficacy in older adults with low back pain (LBP). The 2019 study, conducted at the University of São Paulo in partnership with the Federal University of Paraná (both in Brazil), examined the study groups’ pain intensity levels as well as several secondary factors of patient experience. In the study team’s search for an objective, standardized tool to measure patient satisfaction, they chose to employ the MedRisk Instrument for Measuring Patient Satisfaction (MR-12).
Developed by MedRisk’s academic and research arm Expert Clinical Benchmarks (ECB), the MR-12 is a questionnaire that contains 20 items meant to capture the patient’s experience as it relates to treatment, the service provided and the therapist-patient relationship. Factors range from the interpersonal skills of the therapist and office staff to the education provided to patients to the convenience and cleanliness of the clinic.
While the questionnaire has been a vital tool in strengthening the MedRisk provider network and proprietary patient-to-provider matching system, its effects don’t stop there. Since its initial validation in the United States in 2001, the MR-12 has been translated and culturally adapted for specific populations around the world. To date, it has been utilized in more than 30 countries and has helped identify some of the key factors that positively influence satisfaction in the field at large.
To see just one example of the MR-12’s utility in contemporary physical medicine research, click here.
